Triglyceride profiles in preterm infants reveal dynamic and age-specific trajectories
By
Emma R. Gertel
Victoria Y. Ding
Thanaphong Phongpreecha
Feng Xie
Andrew Parsons
Ivana Marić
Nima Aghaeepour
Karl G. Sylvester
Valerie Y. Chock
John A. Kerner
Camilia R. Martin
David K. Stevenson
Gary M. Shaw
Jonathan D. Reiss
June 12, 2026
Clinical Scorecard: Dynamic and Age-Dependent Triglyceride Patterns in Preterm Infants
At a Glance
Category Detail
Condition Key Mechanisms Triglyceride metabolism affected by gestational age, birth weight, and lipid dosing (source needed). Target Population Care Setting
Key Highlights
TG values peak at approximately two weeks of postnatal age in infants born at 22–25 weeks' gestation (source needed). Lipid emulsion dosing <2 g/kg/day reduces risk of hypertriglyceridemia (source needed). TG distributions differ significantly by gestational age (source needed). No consistent association found between TG levels and major neonatal outcomes (source needed). Age- or weight-based TG reference ranges may be necessary for preterm infants (source needed). Guideline-Based Recommendations
Diagnosis
Management
Withhold intravenous lipid emulsions for TG levels >265 mg/dL (source needed). Monitoring & Follow-up
Risks
Patient & Prescribing Data
Preterm infants <32 weeks' gestation in NICUs.
Lipid emulsion therapy is essential for nutritional needs but requires careful monitoring of TG levels.
Clinical Best Practices
Consider age- or weight-based TG reference ranges for preterm infants (source needed). Evaluate TG levels in the context of gestational age and birth weight (source needed). Related Resources & Content
